OSL oncosil medical ltd

Ann: FY 2023 Strategic Update, page-4

  1. 4,660 Posts.
    lightbulb Created with Sketch. 568
    They wasted time in issuing this strategy in my opinion as nothing in here is new or price sensitive for me ...!

    surprising part is that there is no response from FDA on HDE as my understanding is that FDA has fix time frame within which they respond and that time frame already finished but nothing came out so they must be doing Q&A with FDA in my opinion... !

    there is no sale in UK is the biggest issue Market has with this product which is approved in EU and UK long ago (probably 2 year now) ... IMO.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.010(0.86%)
Mkt cap ! $21.74M
Open High Low Value Volume
$1.17 $1.17 $1.14 $80.47K 69.48K

Buyers (Bids)

No. Vol. Price($)
1 2150 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 7380 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.